Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Hisham K. Abdel Dayem

Ain Shams University hospitals, Abassia, Cairo, Egypt

Title: Multi-drug resistant proteins expression in retinoblastoma in primary enucleated eyes versus eyes enucleated after failure of conservative treatment

Biography

Biography: Hisham K. Abdel Dayem

Abstract

Objective

To compare expression of Multidrug-resistant protein 1/P-glycoprotein (MDR1/Pgp) in retinoblastoma in eyes treated by primary enucleation due to advanced tumor at initial presentation and those enucleated after being resistant to chemotherapy.

Design and Methods

A prospective non randomized masked analysis. of pathology specimens obtained from twenty retinoblastoma patients presenting at the retinoblastoma clinic at ophthalmology department, Ain Shams University Hospitals.  Specimens from  patients who had enucleation were divided into 2 groups. Patients in group 1 underwent primary enucleation due to advanced tumor at presentation. Patients in group 2 underwent secondary enucleation after failure of conservative treatment. Immuno histochemical studies were performed searching for expression of Multidrug-resistant protein 1/P-glycoprotein (MDR1/ Pgp) in the two groups. Patient demographic and eye examination data we collected and reviewed.

Results

Analysis of the primary enucleation group showed high positive, low positive and negative expression in 1 (10%), 2 (20%) and 6 cases (70%) respectively. In secondary enucleation group 5 cases (50%), 3 cases (30%) and 2 cases (20%) showed high positive, low positive and negative expression respectively.

Conclusion

This pilot study though, not being able to demonstrate statistical significance in MDR1 expression in primary enucleated  vs. secondary enucleated resistant cases, demonstrated  p value  low enough to indicate a trend for more MDR1 expression in resistant cases.( P= 0.068),  . Further study with a larger sample size is warranted